rood blauwe elepsis logo Belegger.nl

RELX 2026

410 Posts
Pagina: «« 1 ... 16 17 18 19 20 21 | Laatste | Omlaag ↓
  1. forum rang 6 trab33 13 februari 2026 19:11
    quote:

    dividendverzamelaar schreef op 13 februari 2026 18:44:

    waar is gebleven de pipo die vertelde ons dat we gaan naar 10 euri?? zeker zoeken naar andere slachtovers die komen in een neerwartse spiral
    ben ook aandeelhouder met een klein winstje momenteel maar ik besef maar al te goed dat 1 zwaluw de lente niet maakt .
    Fijn weekend allen en we kijken er al naar uit naar de lente opdat vele zwaluwen mogen terugkeren naar hun nest van vorig jaar
  2. forum rang 4 Dutch trackers 13 februari 2026 19:27
    quote:

    Hopper58 schreef op 13 februari 2026 16:32:

    [...]

    Is het al zover? Salesforce zit op een raket.
    Ja RELX gaat als een komeet.
    Gisteren WKL omgezet in RELX, heeft ca. 10 jaar voorsprong met AI. First movers bereiken een veel grotere markt. Het LT koersdoel van 51,70!EUR past daar wel bij.
  3. forum rang 6 trab33 13 februari 2026 19:37
    quote:

    trab33 schreef op 13 februari 2026 14:49:

    day high afsluiten zo eens een welkome verademing zijn
    ze hebben er toch rekening mee gehouden :)
  4. forum rang 10 bp5ah 13 februari 2026 22:02
    quote:

    dividendverzamelaar schreef op 13 februari 2026 18:44:

    waar is gebleven de pipo die vertelde ons dat we gaan naar 10 euri?? zeker zoeken naar andere slachtoffers die komen in een neerwartse spiral
    Overkant rond 26.5, dus pipo komt maandag dan ook niet denk ik , overkant is maandag dicht ivm pres. day.
  5. forum rang 10 bp5ah 13 februari 2026 22:03
    quote:

    Gadus morhua schreef op 13 februari 2026 21:10:

    Het is wel een beetje een saai aandeel Relx ;)
    ''Maar lekker defensief'' ;)
    Kiek ahold Gadus, alles is veel volatieler nog dan een twintig jaar terug lijkt 't wel.

    Cijferdag is of afstorten of sky high gaan en meestal op de dag en een tussenweg is er vaak niet.
  6. forum rang 8 beleggertje2020 14 februari 2026 01:59
    Ik heb wel alle prachtig mooie winst genomen op RELX en Flowtraders bij kunnen kopen op 25,52 . Bezit nu alleen nog maar 10K stuks Flowtraders . Rest cash !
  7. forum rang 8 Hopper58 14 februari 2026 02:38
    Relx PLC Earnings Call Highlights AI-Led Growth
    TipRanks Auto-Generated Newsdesk

    Feb 14, 2026, 01:18 AM

    Relx PLC’s latest earnings call painted a largely upbeat picture, with broad-based growth, expanding margins, and aggressive cash returns to shareholders. Management acknowledged headwinds from print decline, portfolio changes, and currency, but stressed that AI-driven products and high-value analytics are now the core profit engines across all four divisions.

    Strong Group Financial Performance

    Relx delivered 7% underlying revenue growth, 9% underlying adjusted operating profit growth, and a 10% rise in adjusted EPS at constant currency. The group’s adjusted operating margin improved by about 90 basis points to 34.8%, underscoring significant operational efficiency and pricing power despite top-line drags from print and portfolio actions.

    Robust Cash Generation and Capital Return

    Cash conversion remained exceptionally strong at 99%, with EBITDA surpassing £3.8bn and free cash flow above £2.3bn after £525m of CapEx. Management combined this with a 7% dividend increase to 67.5p and sizeable buybacks, completing £1.5bn in 2025 and launching a further £2.25bn programme for 2026, of which £250m is already deployed.

    Risk: High Growth and Deep AI Integration

    The Risk division continued to act as a growth engine, posting 8% underlying revenue growth and 10% profit growth. More than 90% of divisional revenue now comes from machine-to-machine interactions using embedded AI analytics and decision tools, reinforcing Relx’s position in data-driven risk scoring and fraud prevention.

    STM Momentum and Scientific Volume Growth

    In STM, underlying revenue grew 5% with adjusted operating profit up 7%, supported by rising article volumes. Primary Research submissions surged more than 20% in 2025 and published articles grew 10%, while new platforms like LeapSpace showed early positive traction in higher-value, workflow-oriented solutions for researchers.

    Legal: AI Adoption and Strong Profitability

    The Legal division reported 9% underlying revenue growth and 12% profit growth, powered by rapid AI adoption. The enterprise base for Lexis+ AI more than doubled over the year, with usage rising even faster, and the company is rolling out nearly 300 Protege AI workflows, aiming to embed its tools directly into legal professionals’ daily tasks.

    www.tipranks.com/news/company-announc...
  8. forum rang 8 Hopper58 14 februari 2026 02:38
    Verder:

    Exhibitions: Revenue Recovery and Margin Expansion

    Exhibitions maintained its post-pandemic recovery with 8% underlying revenue and 9% profit growth, while margins expanded by about 250 basis points. Management credited portfolio upgrades and digital initiatives for pushing profitability well above historical levels, even as the global events cycle normalizes.

    Operational Leverage and Margin Upside

    Across the group, cost growth was held below revenue growth, creating clear operational leverage. Risk, STM, and Legal all delivered profit expansion 2–3 percentage points ahead of revenue, and management signalled that adjusted operating profit growth should continue to outpace revenue growth over the medium term.

    Strategic Positioning Around Content + AI

    Executives repeatedly highlighted a strategy built around proprietary content combined with AI and analytics, rather than generic tools. By leveraging curated databases and contributory data, Relx aims to deliver differentiated, hard-to-replicate decision tools that lock in customers and defend against broader software and AI platform competitors.

    Print and Print-Related Revenue Decline

    The company is deliberately shrinking its exposure to legacy print, which drove a more than 20% drop in print-related revenue. Profit from these activities is now on a managed glide path and is expected to decline in the high single digits annually, freeing focus and capital for digital and analytics-led products.

    Portfolio Effects and Revenue Drag

    Portfolio reshaping and the print step-down weighed on reported growth, cutting total group revenue growth at constant currency to 4% versus 7% underlying. In sterling, headline revenue growth was just 2%, but management argued that these moves enhance mix quality and should support more sustainable growth and margins over time.

    Currency Headwinds

    A stronger pound against the U.S. dollar created a translation drag on reported numbers, muting otherwise solid performance. Adjusted operating profit growth in sterling came in at 4%, and adjusted EPS rose 7%, both below constant-currency growth rates, highlighting an external headwind rather than a deterioration in fundamentals.

    M&A Spend Below Long-Term Average

    Acquisition spending reached £270m in 2025, below the roughly £400m ten-year average, as Relx remained selective on deals. Management emphasized that organic development of AI and workflow solutions is the top priority, which may limit near-term inorganic growth but supports disciplined capital allocation.

    Gradual Adoption and Timing Risk

    Some newer markets, especially STM corporate solutions and institutional monetization opportunities, are still in early build-out phases. Management expects these to scale over several years, implying that while the upside is meaningful, investors should anticipate a gradual rather than sudden contribution to group growth.

    Competitive and Market Uncertainty around Workflow Tools

    Investors pressed management on the risk of large software and AI players encroaching on legal and professional workflows, as well as general market volatility. Relx pointed to its deep content moat and integrated tools as a durable advantage, but acknowledged that competitive dynamics and sentiment remain execution risks to monitor.

    Forward-Looking Guidance and Outlook

    Management guided to continued strong underlying revenue growth with profit expanding faster than sales and robust EPS gains on a constant-currency basis. Divisional targets for 2025 call for mid to high-single digit revenue growth with even stronger profit growth, steady CapEx at about 5% of revenue, ongoing buybacks, disciplined leverage around 2–2.5 times, and a continued managed decline in print-related profit.

    Relx’s earnings call underscored a business shifting decisively toward AI-intensive, high-margin analytics while still returning substantial cash to shareholders. Despite currency pressure, print runoff, and competitive questions around workflows, the tone was confident and the numbers supported it, leaving investors focused on how far the company can extend its data and AI advantage.
410 Posts
Pagina: «« 1 ... 16 17 18 19 20 21 | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 467 7.789
AB InBev 3 5.635
Abionyx Pharma 2 29
Ablynx 43 13.357
ABN AMRO 1.583 55.556
ABO-Group 1 29
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 268
Accsys Technologies 24 12.610
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 205
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 15 20.110
Aedifica 3 1.044
Aegon 3.259 324.947
AFC Ajax 538 7.132
Affimed NV 2 6.358
ageas 5.845 109.985
Agfa-Gevaert 15 2.171
Ahold 3.543 74.640
Air France - KLM 1.026 36.006
AIRBUS 1 15
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 469 13.325
Alfen 18 29.559
Allfunds Group 4 1.772
Almunda Professionals (vh Novisource) 651 4.283
Alpha Pro Tech 1 17
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.488 114.842
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.862 253.523
AMG 973 141.440
AMS 3 73
Amsterdam Commodities 307 6.924
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 584
Antonov 22.632 153.607
Aperam 93 15.705
Apollo Alternative Assets 1 17
Apple 5 409
Arcadis 254 9.984
Arcelor Mittal 2.044 322.410
Archos 1 1
Arcona Property Fund 1 305
arGEN-X 18 11.895
Aroundtown SA 1 251
Arrowhead Research 5 9.973
Ascencio 1 39
ASIT biotech 2 697
ASMI 4.109 40.902
ASML 1.769 131.526
ASR Nederland 22 4.621
ATAI Life Sciences 1 7
Atenor Group 1 556
Athlon Group 121 176
Atos 4 3.814
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 36 18.034
Axsome Therapeutics 1 177
Azelis Group 2 28
Azelis Group NV 2 185
Azerion 7 3.857